PMID: 6980899Sep 1, 1982Paper

Binding of human factor VII and VIIa to monocytes

The Journal of Clinical Investigation
G J Broze

Abstract

Human coagulation Factors VII and VIIa bind with equal affinity to monocytes stimulated with endotoxin. Equilibrium binding studies performed at 0 degrees C using 125I-labeled Factor VII and VIIa showed the dissociation constant (Kd) to be congruent to 82 pM with congruent to 3,600 binding sites/monocyte. Ca++ was required for Factor VII and VIIa interaction with monocytes (optimal CaC12 concentration greater than or equal to 2.5 mM) and binding was reversed by the addition of EDTA. The rate of conversion of Factor X to Xa in mixtures containing Factor VIIa and monocytes was directly related to the quantity of Factor VIIa bound to the monocyte surface. Thus the monocyte binding sites appear to represent tissue factor. Competition experiments showed that Factor VII and VIIa bind to the same monocyte sites and further, that unlabeled Factor VII and VIIa have the same affinity for the binding sites as the 125I-labeled proteins.

References

Apr 1, 1975·The Journal of Clinical Investigation·J R MaynardY Nemerson
Mar 1, 1977·The Journal of Clinical Investigation·H RothbergerJ H Vaughan
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·B Osterud, S I Rapaport
Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
May 9, 1977·Biochemical and Biophysical Research Communications·A M FogelmanG Popják
Jun 1, 1976·Annals of Internal Medicine·A I CederbaumH R Roberts
May 10, 1976·The American Journal of Medicine·R J DaveyC E Rath
Sep 1, 1975·Journal of Immunological Methods·W L WestonS K Hecht
Jul 1, 1975·British Journal of Haematology·R P RiversW L Weston
Dec 1, 1974·Annals of Internal Medicine·P M BlattH R Roberts
Feb 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·Y Nemerson, M P Esnouf
Dec 1, 1974·The Journal of Clinical Investigation·J Niemetz, A J Marcus
Jan 18, 1973·The New England Journal of Medicine·M E Gershwin, J K Gude
Jul 19, 1973·The New England Journal of Medicine·C K Kasper
Feb 14, 1974·The New England Journal of Medicine
Oct 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·R G LernerK Lange
Jun 1, 1968·Annals of Internal Medicine·J Koch-Weser
Apr 4, 1969·Analytical Biochemistry·J Babul, E Stellwagen
Sep 23, 1965·The New England Journal of Medicine·J L TullisP Jurigian
Jan 1, 1981·Annals of the New York Academy of Sciences·R A Marlar, J H Griffin
May 1, 1980·The Journal of Experimental Medicine·G A Levy, T S Edgington
Aug 1, 1964·The American Journal of Medicine·C A HALLJ A DEGROOT

❮ Previous
Next ❯

Citations

Jan 6, 1999·Archives of Pharmacal Research·Y N Han, I K Rhee
Apr 14, 2009·Current Atherosclerosis Reports·Claudia P PereiraGabriele Schoedon
Jan 1, 1991·Pharmacology & Therapeutics·C SunderkötterC Sorg
Mar 21, 1985·Biochimica Et Biophysica Acta·G M Rodgers, M A Shuman
Nov 13, 1991·Biochimica Et Biophysica Acta·A R Beaudoin, G Grondin
Apr 1, 1987·Immunology and Cell Biology·J Ryan, C Geczy
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D M SternJ Owen
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R Bach, D B Rifkin
Dec 4, 2009·The Journal of Biological Chemistry·Jolanta Krudysz-AmbloSaulius Butenas
Mar 1, 2007·The Journal of Biological Chemistry·Samit GhoshL Vijaya Mohan Rao
Dec 1, 1984·The Journal of Experimental Medicine·H Rothberger, M P McGee
Jun 1, 1988·The American Review of Respiratory Disease·H A ChapmanD S Fair
Jun 1, 1984·The Journal of Clinical Investigation·T A DrakeM A Sande
Dec 1, 1984·The Journal of Clinical Investigation·D M SternJ Bartos
Jun 1, 1985·The Journal of Clinical Investigation·H A ChapmanD S Fair
Oct 1, 1986·The Journal of Clinical Investigation·D C AltieriA M Capitanio
Feb 1, 1987·The Journal of Clinical Investigation·C F Nathan
Feb 13, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T KellerR Seitz
Dec 29, 2011·Frontiers in Bioscience (Elite Edition)·L Vijaya Mohan RaoUsha R Pendurthi
Jan 1, 1988·CRC Critical Reviews in Biochemistry·R R Bach
Mar 9, 2012·Thrombosis Research·L Vijaya Mohan RaoUsha R Pendurthi
Jan 15, 2008·Thrombosis Research·Elena M EgorinaBjarne Osterud
Jan 24, 2014·Thrombosis and Haemostasis·Florian Langer, Wolfram Ruf
Jul 31, 2008·Journal of Thrombosis and Haemostasis : JTH·M A SovershaevE M Egorina
Aug 29, 2007·Journal of Thrombosis and Haemostasis : JTH·J T B Crawley
Sep 26, 2012·Journal of Thrombosis and Haemostasis : JTH·L V M Rao, U R Pendurthi
Jun 17, 2000·Baillière's Best Practice & Research. Clinical Haematology·G J Miller
Jan 1, 1985·Thrombosis Research·M C van Dam-MierasH C Hemker
Apr 15, 1986·Thrombosis Research·R L EdwardsW Brande

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.